{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T21:26:38Z","timestamp":1784150798754,"version":"3.55.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T00:00:00Z","timestamp":1679443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T00:00:00Z","timestamp":1679443200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006390","name":"University of Lausanne","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006390","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["OBES SURG"],"published-print":{"date-parts":[[2023,5]]},"abstract":"<jats:title>Abstract\n<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Roux-en-Y gastric bypass (RYGB) involves alterations of the gastrointestinal tract resulting in altered absorption. Patients with obesity have a higher prevalence of depression, and antidepressants are often prescribed. Alterations caused by RYGB could modify drug bioavailability and cause potential subtherapeutic plasma concentrations, increasing the risk of depressive relapse. The aim of this study was to describe the evolution of trough drug dose-normalized antidepressant plasma concentrations before and after RYGB.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Materials and Methods<\/jats:title>\n                <jats:p>This naturalistic prospective case series considers patients with trough plasma concentrations in a 1-year timeframe before and after RYGB. Only antidepressants prescribed to at least three patients were included in the present study.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Thirteen patients (<jats:italic>n<\/jats:italic>\u2009=\u200912 females, median age 44\u00a0years, median BMI before intervention\u2009=\u200941.3\u00a0kg\/m<jats:sup>2<\/jats:sup>) were included. Two patients were treated concurrently with fluoxetine and trazodone; the remaining patients were all treated with antidepressant monotherapy. Therapeutic drug monitoring (TDM) values for duloxetine (<jats:italic>n<\/jats:italic>\u2009=\u20093), escitalopram (<jats:italic>n<\/jats:italic>\u2009=\u20094), fluoxetine (<jats:italic>n<\/jats:italic>\u2009=\u20094), and trazodone (<jats:italic>n<\/jats:italic>\u2009=\u20094) before (median 4.7\u00a0weeks) and after (median 21.3\u00a0weeks) RYGB intervention were analyzed. Compared to preintervention, median [interquartile range] decreases in dose-normalized trough plasma concentrations for duloxetine (33% [\u2212\u200947;\u2009\u2212\u200923]), escitalopram (43% [\u2212\u200951;\u2009\u2212\u200931]), fluoxetine (9% [\u2212\u200920; 0.2]), and trazodone (16% [\u2212\u200929; 0.3]) were observed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This study shows a decrease in plasma antidepressant concentrations following RYGB. TDM before and after RYGB, in addition to close monitoring of psychiatric symptomatology, may help optimize antidepressant treatment after bariatric surgery. These results also highlight the need for prospective studies assessing the clinical evidence available through TDM in these patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical Abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1007\/s11695-023-06526-1","type":"journal-article","created":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T17:03:24Z","timestamp":1679504604000},"page":"1422-1430","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The Influence of a Roux-en-Y Gastric Bypass on Plasma Concentrations of Antidepressants"],"prefix":"10.1007","volume":"33","author":[{"given":"Paul","family":"Garin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Favre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Vionnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Frantz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin B.","family":"Eap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8964-2047","authenticated-orcid":false,"given":"Frederik","family":"Vandenberghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,22]]},"reference":[{"issue":"3","key":"6526_CR1","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1001\/archgenpsychiatry.2010.2","volume":"67","author":"FS Luppino","year":"2010","unstructured":"Luppino FS, de Wit LM, Bouvy PF, et al. Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry. 2010;67(3):220\u20139.","journal-title":"Arch Gen Psychiatry"},{"key":"6526_CR2","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.jad.2018.12.113","volume":"246","author":"H Gill","year":"2019","unstructured":"Gill H, Kang S, Lee Y, et al. The long-term effect of bariatric surgery on depression and anxiety. J Affect Disord. 2019;246:886\u201394.","journal-title":"J Affect Disord"},{"issue":"11","key":"6526_CR3","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.amjmed.2010.06.016","volume":"123","author":"HA Tindle","year":"2010","unstructured":"Tindle HA, Omalu B, Courcoulas A, et al. Risk of suicide after long-term follow-up from bariatric surgery. Am J Med. 2010;123(11):1036\u201342.","journal-title":"Am J Med"},{"issue":"5","key":"6526_CR4","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1007\/s11695-013-1131-8","volume":"24","author":"AL Kennedy","year":"2014","unstructured":"Kennedy AL, Nelson T, Pettine S, et al. Medication use following bariatric surgery: factors associated with early discontinuation. Obes Surg. 2014;24(5):696\u2013704.","journal-title":"Obes Surg"},{"issue":"1\u20132","key":"6526_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ijpharm.2010.04.045","volume":"395","author":"KH Yuen","year":"2010","unstructured":"Yuen KH. The transit of dosage forms through the small intestine. Int J Pharm. 2010;395(1\u20132):9\u201316.","journal-title":"Int J Pharm"},{"issue":"6","key":"6526_CR6","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.2337\/dc10-2140","volume":"34","author":"RS Padwal","year":"2011","unstructured":"Padwal RS, Gabr RQ, Sharma AM, et al. Effect of gastric bypass surgery on the absorption and bioavailability of metformin. Diabetes Care. 2011;34(6):1295\u2013300.","journal-title":"Diabetes Care"},{"issue":"6","key":"6526_CR7","first-page":"376","volume":"6","author":"AK Fuller","year":"1986","unstructured":"Fuller AK, Tingle D, DeVane CL, et al. Haloperidol pharmacokinetics following gastric bypass surgery. J Clin Psychopharmacol. 1986;6(6):376\u20138.","journal-title":"J Clin Psychopharmacol"},{"issue":"2","key":"6526_CR8","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/JCP.0b013e318210b203","volume":"31","author":"AC Tripp","year":"2011","unstructured":"Tripp AC. Lithium toxicity after Roux-en-Y gastric bypass surgery. J Clin Psychopharmacol. 2011;31(2):261\u20132.","journal-title":"J Clin Psychopharmacol"},{"issue":"3","key":"6526_CR9","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1177\/0897190020905467","volume":"34","author":"IR McGrane","year":"2021","unstructured":"McGrane IR, Salyers LA, Molinaro JR, et al. Roux-en-Y gastric bypass and antipsychotic therapeutic drug monitoring: two cases. J Pharm Pract. 2021;34(3):503\u20136.","journal-title":"J Pharm Pract"},{"issue":"10","key":"6526_CR10","doi-asserted-by":"publisher","first-page":"4289","DOI":"10.1007\/s11695-020-04969-4","volume":"31","author":"KJ Steffen","year":"2021","unstructured":"Steffen KJ, Mohammad AS, Roerig JL, et al. Lisdexamfetamine pharmacokinetic comparison between patients who underwent Roux-en-Y gastric bypass and nonsurgical controls. Obes Surg. 2021;31(10):4289\u201394.","journal-title":"Obes Surg"},{"issue":"1","key":"6526_CR11","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.soard.2010.12.003","volume":"8","author":"JL Roerig","year":"2012","unstructured":"Roerig JL, Steffen K, Zimmerman C, et al. Preliminary comparison of sertraline levels in postbariatric surgery patients versus matched nonsurgical cohort. Surg Obes Relat Dis. 2012;8(1):62\u20136.","journal-title":"Surg Obes Relat Dis"},{"issue":"4","key":"6526_CR12","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1097\/JCP.0b013e3182905ffb","volume":"33","author":"JL Roerig","year":"2013","unstructured":"Roerig JL, Steffen KJ, Zimmerman C, et al. A comparison of duloxetine plasma levels in postbariatric surgery patients versus matched nonsurgical control subjects. J Clin Psychopharmacol. 2013;33(4):479\u201384.","journal-title":"J Clin Psychopharmacol"},{"issue":"11","key":"6526_CR13","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1002\/phar.2022","volume":"37","author":"CA Krieger","year":"2017","unstructured":"Krieger CA, Cunningham JL, Reid JM, et al. Comparison of bioavailability of single-dose extended-release venlafaxine capsules in obese patients before and after gastric bypass surgery.Ther Drug Monit\n. 2002;24(4):563\u20136.","journal-title":"Pharmacotherapy."},{"issue":"3","key":"6526_CR14","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1097\/FTD.0000000000000146","volume":"37","author":"MA Marzinke","year":"2015","unstructured":"Marzinke MA, Petrides AK, Steele K, et al. Decreased escitalopram concentrations post-Roux-en-Y gastric bypass surgery. Ther Drug Monit. 2015;37(3):408\u201312.","journal-title":"Ther Drug Monit"},{"issue":"3","key":"6526_CR15","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1007\/s11695-020-05048-4","volume":"31","author":"F Vandenberghe","year":"2021","unstructured":"Vandenberghe F, Gilet P, Daali Y, et al. Bioavailability of vortioxetine after a Roux-en-Y gastric bypass. Obes Surg. 2021;31(3):1353\u20136.","journal-title":"Obes Surg"},{"issue":"3","key":"6526_CR16","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1176\/appi.ajp.2011.11050719","volume":"169","author":"GG Hamad","year":"2012","unstructured":"Hamad GG, Helsel JC, Perel JM, et al. The effect of gastric bypass on the pharmacokinetics of serotonin reuptake inhibitors. Am J Psychiatry. 2012;169(3):256\u201363.","journal-title":"Am J Psychiatry"},{"issue":"12","key":"6526_CR17","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1007\/s00228-021-03182-1","volume":"77","author":"SM Wallerstedt","year":"2021","unstructured":"Wallerstedt SM, Nylen K, Axelsson MAB. Serum concentrations of antidepressants, antipsychotics, and antiepileptics over the bariatric surgery procedure. Eur J Clin Pharmacol. 2021;77(12):1875\u201385.","journal-title":"Eur J Clin Pharmacol"},{"issue":"7","key":"6526_CR18","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1007\/s11695-018-3283-z","volume":"28","author":"L Busetto","year":"2018","unstructured":"Busetto L, Dicker D, Azran C, et al. Obesity management task force of the European Association for the Study of Obesity Released \u201cPractical Recommendations for the Post-Bariatric Surgery Medical Management.\u201d Obes Surg. 2018;28(7):2117\u201321.","journal-title":"Obes Surg"},{"issue":"4","key":"6526_CR19","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.soard.2016.02.008","volume":"12","author":"S Sogg","year":"2016","unstructured":"Sogg S, Lauretti J, West-Smith L. Recommendations for the presurgical psychosocial evaluation of bariatric surgery patients. Surg Obes Relat Dis. 2016;12(4):731\u201349.","journal-title":"Surg Obes Relat Dis"},{"key":"6526_CR20","unstructured":"Directives pour le traitement chirurgical de l\u2019ob\u00e9sit\u00e9: Swiss Society for the Study of Morbid Obesity and Metabolic Disorders; 2021 [updated 01.07.2021. Available from: https:\/\/www.smob.ch\/fr\/directives\/medicales."},{"issue":"2","key":"6526_CR21","first-page":"121","volume":"13","author":"SI Ankier","year":"1991","unstructured":"Ankier SI, Warrington SJ, Sneddon JM. A pharmacokinetic and dynamic study of single nightly doses of conventional and controlled release formulations of trazodone. Methods Find Exp Clin Pharmacol. 1991;13(2):121\u20137.","journal-title":"Methods Find Exp Clin Pharmacol"},{"issue":"4","key":"6526_CR22","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1097\/00007691-200208000-00016","volume":"24","author":"K Mihara","year":"2002","unstructured":"Mihara K, Yasui-Furukori N, Kondo T, et al. Relationship between plasma concentrations of trazodone and its active metabolite, m-Chlorophenylpiperazine, and its clinical effect in depressed patients. Ther Drug Monit. 2002;24(4):563\u20136.","journal-title":"Ther Drug Monit"},{"issue":"2","key":"6526_CR23","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1177\/00912700022008810","volume":"40","author":"A Sharma","year":"2000","unstructured":"Sharma A, Goldberg MJ, Cerimele BJ. Pharmacokinetics and safety of duloxetine, a dual-serotonin and norepinephrine reuptake inhibitor. J Clin Pharmacol. 2000;40(2):161\u20137.","journal-title":"J Clin Pharmacol"},{"issue":"12","key":"6526_CR24","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1177\/0091270005280860","volume":"45","author":"B Sogaard","year":"2005","unstructured":"Sogaard B, Mengel H, Rao N, et al. The pharmacokinetics of escitalopram after oral and intravenous administration of single and multiple doses to healthy subjects. J Clin Pharmacol. 2005;45(12):1400\u20136.","journal-title":"J Clin Pharmacol"},{"key":"6526_CR25","unstructured":"Prozac Drug Approval Package: U.S. Food and Drug Administration; 1987 [updated 2017."},{"issue":"1\u201302","key":"6526_CR26","first-page":"9","volume":"51","author":"C Hiemke","year":"2018","unstructured":"Hiemke C, Bergemann N, Clement HW, et al. Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017. Pharmacopsychiatry. 2018;51(1\u201302):9\u201362.","journal-title":"Pharmacopsychiatry"},{"key":"6526_CR27","unstructured":"Team RC. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing; 2021."},{"issue":"6","key":"6526_CR28","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1097\/SLA.0000000000002538","volume":"268","author":"C Duvoisin","year":"2018","unstructured":"Duvoisin C, Favre L, Allemann P, et al. Roux-en-Y gastric bypass: ten-year results in a cohort of 658 patients. Ann Surg. 2018;268(6):1019\u201325.","journal-title":"Ann Surg"},{"issue":"6","key":"6526_CR29","first-page":"572","volume":"26","author":"S Rotzinger","year":"1998","unstructured":"Rotzinger S, Fang J, Baker GB. Trazodone is metabolized to m-chlorophenylpiperazine by CYP3A4 from human sources. Drug Metab Dispos. 1998;26(6):572\u20135.","journal-title":"Drug Metab Dispos"},{"issue":"5","key":"6526_CR30","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s00423-019-01784-z","volume":"404","author":"P Plaeke","year":"2019","unstructured":"Plaeke P, Van Den Eede F, Gys B, et al. Postoperative continuation of antidepressant therapy is associated with reduced short-term weight loss following Roux-en-Y gastric bypass surgery. Langenbecks Arch Surg. 2019;404(5):621\u201331.","journal-title":"Langenbecks Arch Surg"},{"issue":"1","key":"6526_CR31","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.psym.2019.10.009","volume":"61","author":"M Hawkins","year":"2020","unstructured":"Hawkins M, Leung SE, Lee A, et al. Psychiatric medication use and weight outcomes one year after bariatric surgery. Psychosomatics. 2020;61(1):56\u201363.","journal-title":"Psychosomatics"},{"issue":"5","key":"6526_CR32","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1001\/jamasurg.2017.5025","volume":"153","author":"AP Courcoulas","year":"2018","unstructured":"Courcoulas AP, King WC, Belle SH, et al. Seven-year weight trajectories and health outcomes in the Longitudinal Assessment of Bariatric Surgery (LABS) Study. JAMA Surg. 2018;153(5):427\u201334.","journal-title":"JAMA Surg"},{"issue":"3","key":"6526_CR33","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1007\/s40519-020-00930-7","volume":"26","author":"MM Geerts","year":"2021","unstructured":"Geerts MM, van den Berg EM, van Riel L, et al. Behavioral and psychological factors associated with suboptimal weight loss in post-bariatric surgery patients. Eat Weight Disord. 2021;26(3):963\u201372.","journal-title":"Eat Weight Disord"},{"issue":"3","key":"6526_CR34","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s12170-016-0492-7","volume":"10","author":"NJ Switzer","year":"2016","unstructured":"Switzer NJ, Debru E, Church N, et al. The impact of bariatric surgery on depression: a review. Curr Cardiovasc Risk Rep. 2016;10(3):12.","journal-title":"Curr Cardiovasc Risk Rep"},{"issue":"11","key":"6526_CR35","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1111\/obr.12434","volume":"17","author":"C Azran","year":"2016","unstructured":"Azran C, Wolk O, Zur M, et al. Oral drug therapy following bariatric surgery: an overview of fundamentals, literature and clinical recommendations. Obes Rev. 2016;17(11):1050\u201366.","journal-title":"Obes Rev"}],"container-title":["Obesity Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-023-06526-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11695-023-06526-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-023-06526-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T13:25:47Z","timestamp":1684243547000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11695-023-06526-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,22]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["6526"],"URL":"https:\/\/doi.org\/10.1007\/s11695-023-06526-1","relation":{},"ISSN":["0960-8923","1708-0428"],"issn-type":[{"value":"0960-8923","type":"print"},{"value":"1708-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,22]]},"assertion":[{"value":"8 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Frederik Vandenberghe received honoraria for conferences or teaching CME courses from Forum f\u00fcr Medizinische Fortbildung and Sysmex Suisse AG. Chin B. Eap received honoraria for conferences or teaching CME courses from Forum f\u00fcr Medizinische Fortbildung, Janssen-Cilag, Lundbeck, Mepha, Otsuka, Sandoz, Servier, Takeda, Vifor-Pharma, and Zeller in the past 3\u00a0years. The other authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}